BioPharma Dive February 3, 2025
Kelly Bilodeau

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

An H5N1 outbreak is killing flocks of wild birds in Massachusetts and sickening dairy cows in 16 states while a new strain of H5N9 bird flu has emerged in California. As bird flu continues to spread among animals, experts are on high alert for the possibility of the virus acquiring the ability to trigger an outbreak in humans.

For now, the risk to people is still low, even with a new strain on the rise.

“While the 67 human avian influenza cases can be tracked back to an animal source, there has been no reported human-to-human transmission — if...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Heart health differences in men and women: Tiny RNA molecules play key role, study finds
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
Healthcare supply chain, pharmacy costs to rise in 2025: report
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
New Data Shed Light on Who Stops Using GLP-1 Drugs, and Why

Share This Article